Walid Sireis

944 total citations
21 papers, 585 citations indexed

About

Walid Sireis is a scholar working on Biochemistry, Management of Technology and Innovation and Infectious Diseases. According to data from OpenAlex, Walid Sireis has authored 21 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biochemistry, 7 papers in Management of Technology and Innovation and 6 papers in Infectious Diseases. Recurrent topics in Walid Sireis's work include Blood transfusion and management (9 papers), Blood donation and transfusion practices (7 papers) and Hepatitis B Virus Studies (4 papers). Walid Sireis is often cited by papers focused on Blood transfusion and management (9 papers), Blood donation and transfusion practices (7 papers) and Hepatitis B Virus Studies (4 papers). Walid Sireis collaborates with scholars based in Germany, United States and United Kingdom. Walid Sireis's co-authors include Erhard Seifried, Michael Schmidt, M. K. Hourfar, W. Kurt Roth, W. Weichert, Christian Drosten, Hubert Schrezenmeier, Volkhard A. J. Kempf, Halvard Bönig and Wolf‐Jochen Geilenkeuser and has published in prestigious journals such as Transfusion, Bone Marrow Transplantation and Vox Sanguinis.

In The Last Decade

Walid Sireis

21 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walid Sireis Germany 14 236 179 167 162 150 21 585
Robert Crookes South Africa 11 370 1.6× 96 0.5× 326 2.0× 148 0.9× 71 0.5× 16 732
Shigeharu Uchida Japan 14 296 1.3× 76 0.4× 225 1.3× 43 0.3× 107 0.7× 45 694
Mila Lebedeva United States 10 223 0.9× 77 0.4× 75 0.4× 25 0.2× 266 1.8× 10 801
Catherine Mundy Malawi 12 213 0.9× 22 0.1× 35 0.2× 64 0.4× 314 2.1× 15 657
L. H. Barbosa United States 12 873 3.7× 14 0.1× 816 4.9× 67 0.4× 201 1.3× 16 1.1k
Robin Biswas United States 10 432 1.8× 15 0.1× 389 2.3× 39 0.2× 78 0.5× 18 535
L. Jeffers United States 11 235 1.0× 13 0.1× 218 1.3× 22 0.1× 69 0.5× 24 511
Dawn C. Ward United States 9 99 0.4× 54 0.3× 6 0.0× 41 0.3× 61 0.4× 32 809
Alexander Jordan United States 10 425 1.8× 7 0.0× 41 0.2× 17 0.1× 467 3.1× 21 620
R. Mitchell United Kingdom 12 798 3.4× 79 0.4× 26 0.2× 35 0.2× 413 2.8× 40 1.2k

Countries citing papers authored by Walid Sireis

Since Specialization
Citations

This map shows the geographic impact of Walid Sireis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Sireis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Sireis more than expected).

Fields of papers citing papers by Walid Sireis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid Sireis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Sireis. The network helps show where Walid Sireis may publish in the future.

Co-authorship network of co-authors of Walid Sireis

This figure shows the co-authorship network connecting the top 25 collaborators of Walid Sireis. A scholar is included among the top collaborators of Walid Sireis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walid Sireis. Walid Sireis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Michael, M. K. Hourfar, Walid Sireis, et al.. (2015). Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion‐transmitted bacterial strains. Transfusion. 55(9). 2104–2112. 43 indexed citations
2.
Klarmann, Dieter, Walid Sireis, Michael Hogardt, et al.. (2014). A validation protocol and evaluation algorithms to determine compatibility of cell therapy product matrices in microbiological testing. Cell and Tissue Banking. 16(3). 311–318. 10 indexed citations
3.
Schmidt, Michael, et al.. (2013). Emerging Pathogens - How Safe is Blood?. Transfusion Medicine and Hemotherapy. 41(1). 10–17. 32 indexed citations
4.
Hahn, Seung Min, Walid Sireis, Darja Karpova, et al.. (2013). Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates. Bone Marrow Transplantation. 49(3). 338–348. 15 indexed citations
5.
Mueller, Markus M., M. K. Hourfar, E. Huber, et al.. (2012). Oxygen measurements in platelet fluids – a new non‐invasive method to detect bacterial contaminations in platelets. Transfusion Medicine. 22(3). 211–216. 5 indexed citations
6.
7.
Meier, Jens, et al.. (2012). Perioperative Red Blood Cell Transfusion: Harmful or Beneficial to the Patient?. Transfusion Medicine and Hemotherapy. 39(2). 98–103. 12 indexed citations
8.
Seidl, Christian, Walid Sireis, Giuliano Grazzini, et al.. (2012). Blood collection and processing. Quality guidelines and standards reflecting common best practice standards referring to the EuBIS manual and guide. ISBT Science Series. 7(1). 16–23. 3 indexed citations
9.
Schmidt, Michael, Walid Sireis, & Erhard Seifried. (2011). Implementation of Bacterial Detection Methods into Blood Donor Screening – Overview of Different Technologies. Transfusion Medicine and Hemotherapy. 38(4). 259–265. 19 indexed citations
10.
Sireis, Walid, Brigitte Rüster, M. K. Hourfar, et al.. (2011). Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany. Vox Sanguinis. 101(3). 191–199. 30 indexed citations
11.
Hourfar, M. K., U. Mayr‐Wohlfart, Walid Sireis, et al.. (2010). Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion. 51(1). 129–136. 32 indexed citations
12.
Henschler, Reinhard, et al.. (2010). Production of standard blood components. ISBT Science Series. 5(n1). 190–195. 1 indexed citations
13.
Schmidt, Michael, Klaus Korn, C. Micha Nübling, et al.. (2009). First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion. 49(9). 1836–1844. 53 indexed citations
14.
Walther‐Wenke, Gabriele, Hubert Schrezenmeier, Gabriele Geis, et al.. (2009). Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportionof transfused units, and clinical follow-up. Annals of Hematology. 89(1). 83–91. 49 indexed citations
15.
Hourfar, M. K., Karin Janetzko, Knut Gubbe, et al.. (2008). Sensitivity and specificity of Anti‐HBc screening assays – which assay is best for blood donor screening?. International Journal of Laboratory Hematology. 31(6). 649–656. 31 indexed citations
16.
Sireis, Walid, et al.. (2008). Accumulation of soluble inflammatory mediators between blood donation and pre‐storage leucocyte depletion. Vox Sanguinis. 96(2). 163–166. 13 indexed citations
17.
Schmidt, Michael, Julia E. Heck, Thomas Montag, et al.. (2005). Optimized Scansystem™ platelet kit for bacterial detection with enhanced sensitivity: detection within 24 h after spiking. Vox Sanguinis. 89(3). 135–139. 27 indexed citations
18.
Heiden, M., et al.. (2004). Plasma quality after whole‐blood filtration depends on storage temperature and filter type. Transfusion Medicine. 14(4). 297–304. 19 indexed citations
19.
Roth, W. Kurt, et al.. (2002). Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion. 42(7). 862–868. 68 indexed citations
20.
Roth, W. Kurt, et al.. (2002). NAT for HBV and anti‐HBc testing increase blood safety. Transfusion. 42(7). 869–875. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Crookes Breakdown of academic impact, for papers by Shigeharu Uchida Breakdown of academic impact, for papers by Mila Lebedeva Breakdown of academic impact, for papers by Catherine Mundy Breakdown of academic impact, for papers by L. H. Barbosa Breakdown of academic impact, for papers by Robin Biswas Breakdown of academic impact, for papers by L. Jeffers Breakdown of academic impact, for papers by Dawn C. Ward Breakdown of academic impact, for papers by Alexander Jordan Breakdown of academic impact, for papers by R. Mitchell
Rankless by CCL
2026